Paul Dranichnikov

Paul Dranichnikov serves as an Affiliated Researcher at the Centre for Research & Development, Gävleborg and as a Physician specializing in Gastrointestinal Surgery within the Department of Surgical Sciences at Uppsala University's Faculty of Medicine. His clinical practice spans both Gävle Hospital and Akademiska University Hospital in Uppsala, focusing on complex surgical oncology procedures.

His research centers on cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) for peritoneal metastases, with particular emphasis on postoperative outcomes, fluid management, coagulopathy risks, and thromboembolic events. Key interests include:

• Peritoneal surface malignancy management
• HIPEC protocol optimization
• Postoperative morbidity reduction
• Perioperative risk stratification
• Oncologic surgical outcomes research

Analysis of his publications reveals consistent focus on improving safety and efficacy of cytoreductive procedures through rigorous clinical studies, including propensity-matched analyses and biomarker investigations. His 2022 doctoral thesis 'HIPECology' established foundational work in postoperative morbidity following HIPEC procedures.

While no formal awards are documented, his research demonstrates significant contributions to surgical oncology through high-impact publications in journals including European Journal of Surgical Oncology and Annals of Surgical Oncology. His collaborative work with prominent researchers like Wilhelm Graf and Peter Cashin underscores integration within major oncology research networks.